Effect of Sildenafil Citrate on Pulmonary Arterial Systolic Pressure and Sub-maximal Exercise Capacity in Chronic Obstructive Pulmonary Disease.

医学 西地那非 慢性阻塞性肺病 肺动脉高压 内科学 心脏病学 血压 肺康复 麻醉
作者
Sony Shrestha,B. N. Srivastava,Manan Karki,Devendra Khatri,Ramanna Pradhan
出处
期刊:PubMed [National Institutes of Health]
卷期号:15 (60): 271-278 被引量:8
链接
标识
摘要

Background Pulmonary hypertension (PH) often complicates Chronic Obstructive Pulmonary Disease (COPD). Sildenafil reduces pulmonary arterial pressure associated with multitude of diseases. Objective To evaluate the use of Sildenafil in Pulmonary Hypertension associated with COPD. Method This randomized control study enrolled 72 patients: 61 completed the study. Thirtypatients with COPD received Sildenafil 25 mg thrice daily and 31 patients with COPD received optimal medical therapy for four weeks. Symptom assessment and dyspnoea grading was done with modified Borg scale and Modified Medical Research Council (MMRC) grade. The functional assessment was done with WHO functional classification. The estimation of pulmonary arterial systolic pressure and six minute walking distance was done before and after four weeks of the administration of therapy in both groups. Adverse reaction profiling was done for Sildenafil. The primary outcomes were the changes in pulmonary arterial systolic pressure and six minute walk test. The secondary outcomes were change in modified Borg scale for dyspnoea, MMRC grading and WHO functional class. Result The mean decrease in pulmonary arterial systolic pressure in Sildenafil group was significant as compared to controls (9.87+7.84 mmHg Vs 5.93+7.44 mmHg, P=0.048). The mean increase in six minute walk distance was significantly more in cases as compared to controls (48.13+25.79 m Vs 32.59+32.96 m,P=0.047). The changes in modified Borg scale was not significant (1.20+1.92 to 1.55+1.23; P=0.401). There was significant changes in MMRC grade (p=0.037). There was no significant change in WHO functional class after four weeks (p=0.071). Conclusion Sildenafil marginally decreased pulmonary arterial systolic pressure and increased six minute walk distance in COPD patients. It improved MMRC grading without affecting modified Borg's Scale and WHO functional class.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
waitamoment完成签到,获得积分10
1秒前
研友_nPxRRn完成签到,获得积分10
2秒前
yuyu877完成签到,获得积分10
3秒前
大方海完成签到,获得积分10
3秒前
有你在前方完成签到,获得积分10
3秒前
Akim应助xqx采纳,获得10
4秒前
4秒前
adoudoo完成签到,获得积分10
4秒前
无极微光完成签到,获得积分0
5秒前
WE完成签到,获得积分10
5秒前
许起眸完成签到,获得积分10
6秒前
p454q完成签到 ,获得积分10
6秒前
阿巴阿巴完成签到,获得积分10
6秒前
Aoia完成签到,获得积分10
6秒前
carly完成签到 ,获得积分10
7秒前
Jessie完成签到 ,获得积分10
7秒前
谢焯州完成签到,获得积分10
7秒前
尹冰露完成签到,获得积分10
8秒前
阿巴阿巴发布了新的文献求助10
10秒前
Sampson完成签到,获得积分10
12秒前
健脊护柱完成签到 ,获得积分10
12秒前
12秒前
CadoreK完成签到 ,获得积分10
13秒前
Stitch完成签到,获得积分10
14秒前
1122完成签到 ,获得积分10
15秒前
zhhyi1976完成签到,获得积分10
16秒前
ngyx完成签到 ,获得积分10
18秒前
landolu完成签到,获得积分10
18秒前
甜蜜冷风完成签到,获得积分10
19秒前
Starain完成签到,获得积分10
20秒前
20秒前
xcwy完成签到,获得积分10
20秒前
yl6649084完成签到,获得积分10
21秒前
舒适沛珊完成签到 ,获得积分10
21秒前
阿拉哈哈笑完成签到,获得积分10
21秒前
何甜甜完成签到,获得积分10
21秒前
YeeLeeLee完成签到,获得积分10
21秒前
吴3L完成签到,获得积分10
22秒前
Camellia完成签到,获得积分10
22秒前
免疫小白完成签到 ,获得积分10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Introducing the Learning Sciences 600
Resiliency Scale for Adolescents--Chinese Version 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7324082
求助须知:如何正确求助?哪些是违规求助? 8939526
关于积分的说明 18952645
捐赠科研通 6980909
什么是DOI,文献DOI怎么找? 3215319
关于科研通互助平台的介绍 2382740
邀请新用户注册赠送积分活动 2194620